Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

ABSTRACT: The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized to help select molecular markers and determine the optimal sensitivity and specificity values for the Exact IBD-ACRN surveillance test for colorectal cancer (CRC).

DISEASE(S): Gastrointestinal Diseases,Inflammatory Bowel Diseases,Intestinal Diseases,Digestive System Diseases,Colorectal Cancer,Colorectal Neoplasms,Inflammatory Bowel Disease,Colonic Diseases,Neoplasms,Cancer

PROVIDER: 2194581 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Fungi amplicons SysMed IBD

Project description:Evaluation of fungal community in stool samples from SysMed IBD project

| PRJEB29083 | ENA

RNAseq of pedriatic IBD and XIAP-deficient biopsy samples

Project description:Deficiency in the X-linked inhibitor of apoptosis protein (XIAP) is the cause for the X-linked lymphoproliferative syndrome 2 (XLP2). About one third of all patients suffers from severe and therapy refractory inflammatory bowel disease (IBD), but the exact pathogenesis remains undefined. We examined the differences in gene expression of pediatric XLP2 patients with IBD to healthy controls and pediatric IBD patients.

2021-09-20 | GSE183069 | GEO

IBD Virome

Project description:An analysis of the composition of viruses and bacteria in stool samples from IBD patients and healthy controls.

| PRJEB7772 | ENA

Pediatric IBD MLI metaproteomics

Project description:Mucosal-luminal interface (MLI) samples were collected from a cohort of children with new-onset IBD and microbial cells were harvested and processed for metaproteomic analysis. Deep metaproteomics data analysis was then performed for better understanding the MLI microbiota functions in the development of pediatric IBD.

2018-08-03 | PXD007819 | Pride

Application of SWATH Mass Spectrometry and Machine Learning in Diagnosis of Inflammatory Bowel Disease Based on Stool Proteome

Project description:Our hypothesis was that conducting proteomic analysis on clinical laboratory samples which are intended for the fecal calprotectin test would enable the develop-ment of a highly sensitive and specific non-invasive stool test based on mass spec-trometry. To investigate this hypothesis, we combined and applied our expertise in basic research, clinical practice, and bioinformatics to develop a precise ma-chine-learning model for the accurate diagnosis of active IBD from symptomatic non-IBDpatients.

2024-02-01 | PXD047585 | Pride

Dynamic expression of smRNA from fecal exosome in disease progression of an inflammatory bowel disorder mouse model

Project description:Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract affecting over 3 million adults in the United States. Despite being widespread, reliable early diagnostic tests are not available. In order to remedy this, we examined exosomal small RNA (smRNA), specifically targeting microRNA (miRNA) and piRNA from the stool samples of IBD model mice, interleukin 10 knockout mice (IL-10 KO), as a potential diagnostic marker. Stool samples were specifically chosen because they are readily available and collection is noninvasive.

2023-02-19 | GSE167239 | GEO

Transcriptional behavior of regulatory T cells predicts IBD patient responses to vedolizumab therapy

Project description:Vedolizumab (VDZ) is used to treat patients with IBD but the exact way it works is not known. We studied the immune system in the blood and intestine of patients treated with VDZ and found immune characteristics that correlated with response.

2022-08-23 | GSE184593 | GEO

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

Project description:This study aims to determine the performance of the Exact IBD-ACRN surveillance test to detect colorectal cancer (CRC) and colorectal neoplasia in patients with inflammatory bowel disease (IBD). Patients with an IBD diagnosis for at least eight years or diagnosis of primary sclerosing cholangitis (PSC) and who are eligible for CRC screening are eligible to participate in this study. Enrolled subjects will collect a stool sample for the Exact IBD-ACRN surveillance test. Subjects must have undergone colonoscopy no more than 90 days prior to enrollment and will undergo colonoscopy or surgical intervention within 120 days of enrollment. Tissue diagnosis of CRC will be established by histopathologic examination.

| 2142225 | ecrin-mdr-crc

mouse stool sample

Project description:mouse stool samples Metagenome

| PRJNA528776 | ENA

mouse stool sample

Project description:mouse stool samples Metagenome

| PRJNA528778 | ENA